FDA Approves First KRAS-Targeted Therapy for NSCLC
Lung cancer is the number one cause of cancer-related death worldwide. Each year, about 2.2 million new cases of...
Lung cancer is the number one cause of cancer-related death worldwide. Each year, about 2.2 million new cases of...
Primary hyperoxaluria (PH) is a rare genetic disease in which high levels of oxalate are produced and can deposit...
Most vaccines are given as prophylactics, agents that protect healthy individuals before exposure to a pathogen. By contrast, therapeutic...
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...
The human immune system makes antibodies that bind to the same antigen with both of their variable regions, or...
The novel coronavirus (nCoV-19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public health crisis...
US Food and Drug Administration has approved Epclusa an oral, fixed-dose combination drug for adults, containing sofosbuvir 400 mg...
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...
Liraglutide (Victoza®) is an injectable glucagon-like peptide-1 (GLP-1) receptor antagonist indicated in addition to diet and exercise to improve...